期刊文献+

MR泪道钆造影术在泪道阻塞中的应用价值 被引量:1

Application value of gadolinium-enhanced MR dacryocystography in lacrimal duct obstruction
下载PDF
导出
摘要 目的探讨MR泪道钆造影(Gd-MRD)在泪道阻塞中的应用价值。方法选取100例溢泪患者,采用简单随机分组法分成二组,每组50例。Gd-MRD组扫描前向双侧结膜囊内滴入0.01 mol/L的Gd-DTPA稀释液,采用三维快速扰相梯度回波(3D FSPGR)序列、FS FSE T1WI序列和FS FSE T2WI序列;MR泪道成像(MRD)组,扫描前滴入0.9%NaCl注射液,采用三维快速反转自旋回波泪道成像(3D FRFSE)序列和FS FSE T2WI序列。接受MRI检查后2天内进行鼻内镜微创术或泪道鼻腔吻合术。对比分析两种方法的泪道显示情况和梗阻部位,并将影像表现与手术所见对照分析。结果Gd-MRD与MRD在泪小管、泪囊、泪道黏膜显影率、梗阻部位符合率差异有统计学意义(P<0.05),鼻泪管显示率差异无统计学意义(P>0.05)。结论Gd-MRD在泪道显示能力优于MRD,能更好的显示泪道管腔形态及管壁结构,更精确的显示梗阻部位,能为临床医师制定治疗方案提供可靠依据。 Objective To investigate the application value of gadolinium-enhanced MR dacryocystography(Gd-MRD)in lacrimal duct obstruction.Methods 100 patients with epiphora were divided into two groups by simple random grouping,with 50 cases in each group.In Gd-MRD,the 0.01 mol/L Gd-DTPA dilution was dripped into the bilateral conjunctival sac before scanning,using three-dimensionalfast spoiled gradient-recalled(3D FSPGR)sequence,FS FSE T1WI sequence and FS FSE T2WI sequence;In MR dacryocystography(MRD),we injected 0.9%NaCl before scanning,using three-dimensional fast reverse spin echo lacrimal imaging(3D FRFSE)sequence and FS FSE T2WI sequence.Endoscopic examination or dacryocystorhinostomy was performed within 2 days after MR examination.we contrasted and analyzed the lacrimal duct display and obstruction sites of the two methods,and compared the imaging performance with the surgical findings.Results There were significant differences in the displaying rate of lacrimal canaliculus,lacrimal sac,lacrimal duct mucosa and the coincidence rate of obstruction sites(P<0.05),and there was no statistical difference in the display rate of nasolacrimal duct(P>0.05).Conclusion The ability of Gd-MRD to display lacrimal ducts is better than MRD,which can better display the lacrimal duct lumen shape and wall structure,more accurately display the obstruction site,and can provide a reliable basis for clinicians to formulate treatment plans.
作者 丁凯俊 江宏冀 史斌 沈龙 江时淦 彭建波 饶丽望 刘越 DING Kaijun;JIANG Hongji;SHI Bin;SHEN Long;JIANG Shigan;PENG Jianbo;RAO Liwang;LIU Yue(Department of Radiology, First Affiliated Hospital of Jiangxi Medical College, Shangrao 334000, P.R.China;Department of Ophthalmology, First Affiliated Hospital of Jiangxi Medical College, Shangrao 334000, P.R.China)
出处 《医学影像学杂志》 2021年第12期2001-2004,2009,共5页 Journal of Medical Imaging
基金 江西省卫生计生委科技计划项目(编号:20197550)。
关键词 磁共振成像 钆剂 泪囊造影术 泪道阻塞 Magnetic resonance imaging Gadolinium Dacryocystography Lacrimal duct obstruction
  • 相关文献

参考文献7

二级参考文献51

  • 1白芝兰,薛冠英,吴红梅,齐乃新,施小珍,杨立娟.胃肠道阴性对比剂在磁共振胰胆管成像中的应用研究[J].实用放射学杂志,2004,20(10):910-913. 被引量:5
  • 2李文政,彭光春,汤恢焕,陈登明,刘凡,王润文,贾高志,聂吉林.口服枸橼酸铁铵前后MRCP的临床应用[J].中国医学影像技术,2005,21(3):408-410. 被引量:15
  • 3贾沛靓,唐海红,张速勤.鼻内泪囊应用解剖[J].国际耳鼻咽喉头颈外科杂志,2006,30(2):102-104. 被引量:15
  • 4王敏杰,萧毅,田建明,左长京,邵成伟,沈倩瑾.CT泪道造影方法研究(附36例分析)[J].放射学实践,2006,21(6):620-622. 被引量:17
  • 5Weinreb JC, Maravilla KR, Redman HC, et al. Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr, 1984, 8: 835-838.
  • 6Brown JJ, Duncan JR, Heiken JP, et al. Perfluorodtylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology, 1991, 181:455-460.
  • 7Hahn PF,Stark DD,Lewis JM,et al. First clinical trial of a new superparamagnetic irom oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology, 1990,175:695-700.
  • 8Hirohashi S, Hirohashi R, Uchida H, et al. MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent. Radiology, 1997, 203:281-285.
  • 9Papanikolaou N, Karantanas A, Maris T, et al. MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr, 2000,24:229-234.
  • 10Chan JH, Tsui EY, Yuen MK, et al. Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP. Abdom Imaging, 2000,25:405-408.

共引文献51

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部